List of Aptinyx Inc. patents

Patents where

Current Assignee

Name

Aptinyx Inc.

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11530223 Spiro-lactam NMDA receptor modulators and uses thereof	Patent 11530223 was granted and assigned to Aptinyx Inc. on December, 2022 by the United States Patent and Trademark Office.	Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	11530223	December 20, 2022
‌ US Patent 11299495 Spiro-lactam NMDA receptor modulators and uses thereof	Patent 11299495 was granted and assigned to Aptinyx Inc. on April, 2022 by the United States Patent and Trademark Office.	Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	11299495	April 12, 2022
‌ US Patent 11376250 Spiro-lactam NMDA receptor modulators and uses thereof		Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	11376250	July 5, 2022
‌ US Patent 10196401 Spiro-lactam NMDA receptor modulators and uses thereof	Patent 10196401 was granted and assigned to Aptinyx Inc. on February, 2019 by the United States Patent and Trademark Office.	Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	10196401	February 5, 2019
‌ US Patent 11512051 Spiro-lactam NMDA receptor modulators and uses thereof		Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	11512051	November 29, 2022
‌ US Patent 11427585 Spiro-lactam NMDA modulators and methods of using same	Patent 11427585 was granted and assigned to Aptinyx Inc. on August, 2022 by the United States Patent and Trademark Office.	Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	11427585	August 30, 2022
‌ US Patent 10052308 Spiro-lactam NMDA receptor modulators and uses thereof	Patent 10052308 was granted and assigned to Aptinyx Inc. on August, 2018 by the United States Patent and Trademark Office.	Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	10052308	August 21, 2018
‌ US Patent 10195179 Spiro-lactam NMDA receptor modulators and uses thereof	Patent 10195179 was granted and assigned to Aptinyx Inc. on February, 2019 by the United States Patent and Trademark Office.	Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	10195179	February 5, 2019
‌ US Patent 10150769 Spiro-lactam NMDA modulators and methods of using same	Patent 10150769 was granted and assigned to Aptinyx Inc. on December, 2018 by the United States Patent and Trademark Office.	Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	10150769	December 11, 2018
‌ US Patent 10441572 Spiro-lactam NMDA receptor modulators and uses thereof	Patent 10441572 was granted and assigned to Aptinyx Inc. on October, 2019 by the United States Patent and Trademark Office.	Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	10441572	October 15, 2019
‌ US Patent 10441571 Spiro-lactam NMDA receptor modulators and uses thereof	Patent 10441571 was granted and assigned to Aptinyx Inc. on October, 2019 by the United States Patent and Trademark Office.	Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	10441571	October 15, 2019
‌ US Patent 11578072 Spiro-lactam NMDA receptor modulators and uses thereof		Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	11578072	February 14, 2023
‌ US Patent 11370790 Spiro-lactam NMDA modulators and methods of using same		Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	11370790	June 28, 2022
‌ US Patent 10918637 Spiro-lactam NMDA receptor modulators and uses thereof	Patent 10918637 was granted and assigned to Aptinyx Inc. on February, 2021 by the United States Patent and Trademark Office.	Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	10918637	February 16, 2021
‌ US Patent 10961189 Spiro-lactam NMDA receptor modulators and uses thereof	Patent 10961189 was granted and assigned to Aptinyx Inc. on March, 2021 by the United States Patent and Trademark Office.	Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	10961189	March 30, 2021
‌ US Patent 11028095 Spiro-lactam and bis-spiro-lactam NMDA receptor modulators and uses thereof	Patent 11028095 was granted and assigned to Aptinyx Inc. on June, 2021 by the United States Patent and Trademark Office.	Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	11028095	June 8, 2021
‌ US Patent 10273239 Spiro-lactam NMDA receptor modulators and uses thereof	Patent 10273239 was granted and assigned to Aptinyx Inc. on April, 2019 by the United States Patent and Trademark Office.	Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	10273239	April 30, 2019
‌ US Patent 10253032 Spiro-lactam NMDA receptor modulators and uses thereof	Patent 10253032 was granted and assigned to Aptinyx Inc. on April, 2019 by the United States Patent and Trademark Office.	Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	10253032	April 9, 2019
‌ US Patent 10316041 Spiro-lactam NMDA receptor modulators and uses thereof	Patent 10316041 was granted and assigned to Aptinyx Inc. on June, 2019 by the United States Patent and Trademark Office.		Aptinyx Inc.	United States Patent and Trademark Office	10316041	June 11, 2019
‌ US Patent 9504670 Spiro-lactam NMDA receptor modulators and uses thereof	Patent 9504670 was granted and assigned to Aptinyx Inc. on November, 2016 by the United States Patent and Trademark Office.	Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	9504670	November 29, 2016
‌ US Patent 9758525 Spiro-lactam NMDA receptor modulators and uses thereof	Patent 9758525 was granted and assigned to Aptinyx Inc. on September, 2017 by the United States Patent and Trademark Office.	Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	9758525	September 12, 2017
‌ US Patent 9738650 Spiro-lactam NMDA receptor modulators and uses thereof	Patent 9738650 was granted and assigned to Aptinyx Inc. on August, 2017 by the United States Patent and Trademark Office.	Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	9738650	August 22, 2017
‌ US Patent 9579304 Spiro-lactam NMDA receptor modulators and uses thereof	Patent 9579304 was granted and assigned to Aptinyx Inc. on February, 2017 by the United States Patent and Trademark Office.	Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	9579304	February 28, 2017
‌ US Patent 9512134 Spiro-lactam NMDA receptor modulators and uses thereof	Patent 9512134 was granted and assigned to Aptinyx Inc. on December, 2016 by the United States Patent and Trademark Office.	Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	9512134	December 6, 2016
‌ US Patent 9828384 Spiro-lactam NMDA receptor modulators and uses thereof	Patent 9828384 was granted and assigned to Aptinyx Inc. on November, 2017 by the United States Patent and Trademark Office.	Aptinyx Inc.	Aptinyx Inc.	United States Patent and Trademark Office	9828384	November 28, 2017

Results per page:

28 results

0 selected

28 results

0 selected